Relmada Therapeutics, Inc. RLMD Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s shares (diluted)?
- Relmada Therapeutics, Inc. (RLMD) reported shares (diluted) of 86.6M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Relmada Therapeutics, Inc.'s shares (diluted) increased by 184.8% year-over-year, from 30.4M to 86.6M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Relmada Therapeutics, Inc.'s shares (diluted) has grown at a 18.7% compound annual growth rate (CAGR), from 68.7M to 136.3M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.